CDER QM CoE Announces Availability of Progress and Priorities Update

https://www.fda.gov/media/188999/download?attachment=&utm_medium=email&utm_source=govdelivery Today, the Center for Drug Evaluation and Research (CDER) Quantitative Medicine Center of Excellence (QM CoE) is pleased to announce the availability of the 2025 Progress and Priorities Update. Established in 2024, the CDER QM CoE serves as a cooperative, coordinating body that drives innovation and fosters integration of quantitative medicine approaches to advance therapeutic medical product development, inform regulatory decision-making, and promote public health. This progress report highlights the CDER QM CoE's significant accomplishments across three strategic areas: Enterprise Planning and Coordination, Applied Regulatory Science, and Education and Ecosystem Development. The update provides stakeholders with key progress highlights and outlines the CDER QM CoE's evolving priorities for the future, guided by its established vision, mission, and values. The report also details the CDER QM CoE's strategic focus and plans for the coming years as it continues to advance quantitative medicine approaches in regulatory science.